• Polarean Imaging raised US$10.7m (£8.4m) with funds to be used for the FDA submission and preparations for a commercial launch of its drug-device combination. • Completion of clinical trials with positive results represents a significant derisking event for the Group’s technology. • First clinical Unit sales expected in FY21E with continued research unit sales to research institutions. • Bracco Group, a multinational diagnostics business, invested £2.2m
13 Mar 2020
Conditional fundraise of US$10.7m
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Conditional fundraise of US$10.7m
Polarean Imaging Plc (POLX:LON) | 3.9 0 0.0% | Mkt Cap: 8.43m
- Published:
13 Mar 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
13
• Polarean Imaging raised US$10.7m (£8.4m) with funds to be used for the FDA submission and preparations for a commercial launch of its drug-device combination. • Completion of clinical trials with positive results represents a significant derisking event for the Group’s technology. • First clinical Unit sales expected in FY21E with continued research unit sales to research institutions. • Bracco Group, a multinational diagnostics business, invested £2.2m